Oxcarbazepine
NDC 67877-532, Oxcarbazepine, suspension, from Ascend Laboratories, LLC.
- Product NDC
- 67877-532
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213183
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-532 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXCARBAZEPINE60 mg/mL
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-532-58 | 67877053258 | 250 mL in 1 BOTTLE (67877-532-58) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3f36f519-c30c-4929-afa0-9844dc531e3fNADAC price for package 67877053258
GET /v1/drugs/nadac/67877053258
Use it
Look up 67877-532 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-532 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-532. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.